| Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression VA Lasorsa, D Formicola, P Pignataro, F Cimmino, FM Calabrese, J Mora, ... Oncotarget 7 (16), 21840, 2016 | 97 | 2016 |
| HIF-1 transcription activity: HIF1A driven response in normoxia and in hypoxia F Cimmino, M Avitabile, VA Lasorsa, A Montella, L Pezone, S Cantalupo, ... BMC medical genetics 20, 1-15, 2019 | 85 | 2019 |
| Genetic Analysis of the Coronavirus SARS-CoV-2 Host Protease TMPRSS2 in Different Populations R Russo, I Andolfo, VA Lasorsa, A Iolascon, M Capasso Frontiers in genetics 11, 872, 2020 | 61 | 2020 |
| Common variants at 21q22. 3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19 I Andolfo, R Russo, VA Lasorsa, S Cantalupo, BE Rosato, F Bonfiglio, ... Iscience 24 (4), 2021 | 52 | 2021 |
| An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma D Formicola, G Petrosino, VA Lasorsa, P Pignataro, F Cimmino, S Vetrella, ... Journal of translational medicine 14, 1-9, 2016 | 45 | 2016 |
| BAP1 induces cell death via interaction with 14-3-3 in neuroblastoma W Sime, Q Niu, Y Abassi, KC Masoumi, R Zarrizi, JB Køhler, S Kjellström, ... Cell death & disease 9 (5), 458, 2018 | 37 | 2018 |
| Somatic mutations in specific and connected subpathways are associated with short neuroblastoma patients’ survival and indicate proteins targetable at onset of disease MR Esposito, A Binatti, M Pantile, A Coppe, K Mazzocco, L Longo, ... International journal of cancer 143 (10), 2525-2536, 2018 | 34 | 2018 |
| A targeted gene panel for circulating tumor DNA sequencing in neuroblastoma F Cimmino, VA Lasorsa, S Vetrella, A Iolascon, M Capasso Frontiers in Oncology 10, 596191, 2020 | 27 | 2020 |
| miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase FM Orlandella, RM Mariniello, P Mirabelli, AE De Stefano, PLC Iervolino, ... British journal of cancer 123 (3), 426-437, 2020 | 27 | 2020 |
| Genomic coamplification of CDK4/MDM2/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients L Amoroso, M Ognibene, M Morini, M Conte, A Di Cataldo, A Tondo, ... Genes, Chromosomes and Cancer 59 (5), 277-285, 2020 | 27 | 2020 |
| Regulatory Noncoding and Predicted Pathogenic Coding Variants of CCR5 Predispose to Severe COVID-19 S Cantalupo, VA Lasorsa, R Russo, I Andolfo, G D’Alterio, BE Rosato, ... International journal of molecular sciences 22 (10), 5372, 2021 | 25 | 2021 |
| Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene M Avitabile, M Succoio, A Testori, A Cardinale, Z Vaksman, VA Lasorsa, ... Carcinogenesis 41 (3), 284-295, 2020 | 24 | 2020 |
| 19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis VA Lasorsa, F Cimmino, M Ognibene, K Mazzocco, G Erminio, M Morini, ... NPJ genomic medicine 5 (1), 18, 2020 | 23 | 2020 |
| Transcription factors involved in tumorigenesis are over-represented in mutated active DNA-binding sites in neuroblastoma M Capasso, VA Lasorsa, F Cimmino, M Avitabile, S Cantalupo, A Montella, ... Cancer research 80 (3), 382-393, 2020 | 23 | 2020 |
| A new butyrate releaser exerts a protective action against SARS-CoV-2 infection in human intestine L Paparo, MA Maglio, M Cortese, C Bruno, M Capasso, E Punzo, ... Molecules 27 (3), 862, 2022 | 22 | 2022 |
| The TNFRSF13C H159Y Variant Is Associated with Severe COVID-19: A Retrospective Study of 500 Patients from Southern Italy R Russo, I Andolfo, VA Lasorsa, S Cantalupo, R Marra, G Frisso, P Abete, ... Genes 12 (6), 881, 2021 | 20 | 2021 |
| Exploring shared susceptibility between two neural crest cells originating conditions: neuroblastoma and congenital heart disease A Testori, VA Lasorsa, F Cimmino, S Cantalupo, A Cardinale, M Avitabile, ... Genes 10 (9), 663, 2019 | 17 | 2019 |
| Functional characterization of full-length BARD1 strengthens its role as a tumor suppressor in neuroblastoma F Cimmino, M Avitabile, VA Lasorsa, L Pezone, A Cardinale, A Montella, ... Journal of Cancer 11 (6), 1495, 2020 | 14 | 2020 |
| Association of PARP1 polymorphisms with response to chemotherapy in patients with high‐risk neuroblastoma M Avitabile, VA Lasorsa, S Cantalupo, A Cardinale, F Cimmino, ... Journal of Cellular and Molecular Medicine 24 (7), 4072-4081, 2020 | 13 | 2020 |
| FKBP51s signature in peripheral blood mononuclear cells of melanoma patients as a possible predictive factor for immunotherapy S Romano, E Simeone, A D’Angelillo, P D’Arrigo, M Russo, M Capasso, ... Cancer Immunology, Immunotherapy 66, 1143-1151, 2017 | 13 | 2017 |
